Ligand Pharmaceuticals LGND
NASDAQ LGND
$313.21 +2.85 (+0.92%)
As of: Sep 30, 2026 · 3:53 PM EDT

Ligand Pharmaceuticals (LGND) Operating Expenses (2010 - 2026)

Updated

Ligand Pharmaceuticals' Operating Expenses came in at $55.1 million for Q2 2026, up 40.6% from $39.18 million a year earlier and up 60.4% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Operating Expenses (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Ligand Pharmaceuticals reported Operating Expenses of $195.81 million, down 11.7% year-over-year; for FY2025, it was $227.09 million, up 19.7% from FY2024.

  • Operating Expenses carries a five-year compound annual growth rate of 9.7% (FY2020 to FY2025).
  • Going back by year, Operating Expenses was $189.74 million in FY2024 (+56.2%), $121.49 million in FY2023 (-37.1%), $193.21 million in FY2022 (+40.3%) and $137.69 million in FY2021 (-3.8%).
  • The five-year range for quarterly Operating Expenses is $27.99 million (Q1 2024) to $81.55 million (Q1 2025).
  • Year-over-year, Operating Expenses increased in five of the last eight quarters, with growth averaging 33.7%.
  • The fastest year-over-year change in Operating Expenses over five years came in Q1 2025 (growth of 191.4%), and the weakest in Q1 2026 (a decline of 57.9%).
  • Business Quant data shows LGND's Operating Expenses at $34.35 million (Q1 2026), $45.82 million (Q4 2025) and $60.53 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 10.12 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.56 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -9.70 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.09 Bn
10 Ligand Pharmaceuticals 6.18 Bn 2.65 Bn - 55.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 55.10 Mn
Mar 31, 2026 34.35 Mn
Dec 31, 2025 45.82 Mn
Sep 30, 2025 60.53 Mn
Jun 30, 2025 39.18 Mn
Mar 31, 2025 81.55 Mn
Dec 31, 2024 52.45 Mn
Sep 30, 2024 48.67 Mn
Jun 30, 2024 60.63 Mn
Mar 31, 2024 27.99 Mn
Dec 31, 2023 31.46 Mn
Sep 30, 2023 31.91 Mn
Jun 30, 2023 28.35 Mn
Mar 31, 2023 29.77 Mn
Dec 31, 2022 70.48 Mn
Sep 30, 2022 46.88 Mn
Jun 30, 2022 41.46 Mn
Mar 31, 2022 34.38 Mn
Dec 31, 2021 41.28 Mn
Sep 30, 2021 34.60 Mn
API Access

Ligand Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=LGND&period=max&api_key=YOUR_API_KEY